Professional Documents
Culture Documents
Uses Uses
(Similar to FWB) ⚫ Treat cases of clinically significant protein deficiencies
⚫ Can be used for nonspecific treatment of coagulation
Quality Control (OC) factor deficiencies.
⚫ Hct (without AS): 65% - 80%; (with AS): 55% -65% ➢ PF24RT24 and Thawed Plasma: treatment of stable
⚫ Stored at 1°C-6°C. Storage time depends. coagulation factor deficiencies.
⚫ Standard volume must be 250-300 mL ⚫ Thrombotic thrombocytopenic Purpura (TTP) treatment
⚫ PRBCs packed by "opening the unit have a reduced shelf ⚫ Can be used for preparing cryoprecipitate
life of 24 hours. antihemophilic factor units
⚫ Convalescent plasma: provide antibodies to infected
3. Platelet Concentrates (PCs) patients to neutralize pathogens
Description
⚫ Prepared through conventional means (RDPs) or QUALITY CONTROL
collected through apheresis (SDPs). ⚫ Plasma units (except LP) should be frozen within the
⚫ PC preparation: soft spin of WB units (separates RBCs specified time limit.
from PRP), followed by a hard spin of PRP ⚫ Shelf life and storage conditions:
⚫ Prone to bacterial contamination due to its storage ➢ FFP, AFFP and PF24: 1 year at s-18°C; 7 years at $65°C
conditions. ➢ LP: stored at ref temp; expiry is 5 days after the expiry
⚫ Requires constant agitation: promotes oxygen of the WB unit from where it was expressed
circulation. ⚫ Volume should be 200-380 mL for FFP, PF24 and LP. 200-
1,000 mL for AFFP
Uses
⚫ For treating cases of thrombocytopenia or platelet 5. Cryoprecipitate AHF
function disorders
⚫ Prevention of bleeding due to bone marrow hypoplasia Description
⚫ SDPS: prevent febrile reactions, HLA alloimmunizations, ⚫ A.k.a Cryoprecipitate or cryo
and CMV infections ⚫ Contains a precipitated concentration of factor VIII
(Antihemophilic Factor A)
QC ⚫ Prepared from FFP thawed at 1°C -6°C
⚫ Must contain 5.5 x 10%/L platelets (RDPs) or 3.0 x 1011/L ⚫ Separation of AHF is done by applying a hard spin on the
(SDPs) thawed plasma at 4°C.
⚫ pH should be maintained at > 6.2 ⚫ Also allows the harvesting of other components:
⚫ Stored at RT (20°C-24°C), placed on a platelet agitator, ➢ Fibrinogen
and turned on to apply constant agitation ➢ XIII
⚫ Shelf life is 5 days ➢ vWF
⚫ Volume ➢ Cryoglobulin
SDPS: 200-400 mL ➢ Fibronectin
RDPS: 50-70 mL
⚫ A “swirling phenomenon” must be observed Uses
⚫ Transfused to treat clotting factor deficiencies, notably
4. Plasma Units in these cases:
Description ➢ Hypofibrinogenemia
⚫ Prepared from the centrifugation of whole blood units or ➢ Factor XIII Deficiency
from platelet-rich plasma units (as Platelet-poor Plasma). ➢ Second-line therapy for von Willebrand's Disease,
⚫ Contains the following substances: Hemophilia A, and uremic bleeding
➢ Contains normal amounts of coagulation factors,
antithrombin, and ADAMTS13
➢ 300 mg Fibrinogen/100 mL
➢ 1 IU/mL of Factor V and VIII
QC
⚫ Can be stored frozen for 1 year at s-18 C
⚫ Thawed units must be transfused, frozen within or 6
hours
⚫ Pooled units have a shorter shelf life, lasting for 4 hours
only
⚫ AABB
➢ 80 IU/unit Factor VIII
➢ 150 mg fibrinogen
➢ 170 IU Ristocetin cofactor
➢ 60 IU Factor XIII